SANDOZ BV
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- LANSOPRAZOLO SANDOZ BV gastro-resistant capsule, hard 15 mg
- LANSOPRAZOLO SANDOZ BV gastro-resistant capsule, hard 30 mg
- OMEPRAZOLO SANDOZ BV powder for solution for infusion 40 mg
- A10 - Antidiabéticos
- GLICLAZIDE SANDOZ BV modified-release tablet 60 mg
- C08 - Bloqueantes del canal de calcio
- DILTIAZEM SANDOZ BV prolonged-release capsule, hard 200 mg
- J01 - Antibacterianos para uso sistémico
- BAMKLA powder for oral suspension 600 mg/5 ml+42.9 mg/5 ml
- L01 - Antineoplásicos
- BORTEZOMIB SANDOZ BV powder for solution for injection 2.5 mg
- PEMETREXED SANDOZ BV concentrate for solution for infusion 1 000 mg/40 ml
- PEMETREXED SANDOZ BV concentrate for solution for infusion 100 mg/4 ml
- PEMETREXED SANDOZ BV concentrate for solution for infusion 500 mg/20 ml
- N05 - Psicolépticos
- QUETIAPINA SANDOZ BV prolonged-release tablet 150 mg
- QUETIAPINA SANDOZ BV prolonged-release tablet 200 mg
- QUETIAPINA SANDOZ BV prolonged-release tablet 300 mg
- QUETIAPINA SANDOZ BV prolonged-release tablet 400 mg
- QUETIAPINA SANDOZ BV prolonged-release tablet 50 mg
- N06 - Psicoanalépticos
- CITALOPRAM SANDOZ BV film-coated tablet 20 mg
- CITALOPRAM SANDOZ BV film-coated tablet 40 mg